Journal article
GLI2 promoter hypermethylation in saliva of children with a respiratory allergy
Clinical epigenetics, Vol.10(1), pp.50-50
2018
DOI: 10.1186/s13148-018-0484-1
PMCID: PMC5896137
PMID: 29682088
Abstract
The prevalence of respiratory allergy in children is increasing. Epigenetic DNA methylation changes are plausible underlying molecular mechanisms.
Saliva samples collected in substudies of two longitudinal birth cohorts in Belgium (FLEHS1 & FLEHS2) were used to discover and confirm DNA methylation signatures that can differentiate individuals with respiratory allergy from healthy subjects. Genome-wide analysis with Illumina Methylation 450K BeadChips revealed 23 differentially methylated gene regions (DMRs) in saliva from 11y old allergic children (N=26) vs. controls (N=20) in FLEHS1. A subset of 7 DMRs was selected for confirmation by iPLEX MassArray analysis. First, iPLEX analysis was performed in the same 46 FLEHS1 samples for analytical confirmation of the findings obtained during the discovery phase. iPLEX results correlated significantly with the 450K array data (
<0.0001) and confirmed 4 out of the 7 DMRs. Aiming for additional biological confirmation, the 7 DMRs were analyzed using iPLEX in a substudy of an independent birth cohort (FLEHS2; N=19 cases vs. 20 controls, aged 5 years). One DMR in the
promoter region showed a consistent statistically significant hypermethylation in individuals with respiratory allergy across the two birth cohorts and technologies. In addition to its involvement in TGF-β signaling and T-helper differentiation,
has a regulating role in lung development.
is considered an interesting candidate DNA methylation marker for respiratory allergy.
Details
- Title: Subtitle
- GLI2 promoter hypermethylation in saliva of children with a respiratory allergy
- Creators
- Sabine A S Langie - Hasselt UniversityMatthieu Moisse - KU LeuvenKatarzyna Szarc Vel Szic - University of AntwerpEllen Van Der Plas - University of AntwerpGudrun Koppen - VITO- Sustainable Health, Mol, BelgiumSofie De Prins - VITO- Sustainable Health, Mol, BelgiumTijs Louwies - VITO- Sustainable Health, Mol, BelgiumVera Nelen - Environment and Health unit, Provincial Institute of Hygiene, Antwerp, BelgiumGuy Van Camp - University of AntwerpDiether Lambrechts - KU LeuvenGreet Schoeters - University of AntwerpWim Vanden Berghe - University of AntwerpPatrick De Boever - Hasselt University
- Resource Type
- Journal article
- Publication Details
- Clinical epigenetics, Vol.10(1), pp.50-50
- DOI
- 10.1186/s13148-018-0484-1
- PMID
- 29682088
- PMCID
- PMC5896137
- NLM abbreviation
- Clin Epigenetics
- ISSN
- 1868-7075
- eISSN
- 1868-7083
- Grant note
- DOI: 10.13039/501100001961, name: AXA Research Fund; name: CEFIC-LRI Innovative Science Award 2013; DOI: 10.13039/501100003130, name: Fonds Wetenschappelijk Onderzoek, award: 12L5216N; DOI: 10.13039/100000865, name: Bill and Melinda Gates Foundation, award: OPP119403
- Language
- English
- Date published
- 2018
- Academic Unit
- Psychiatry
- Record Identifier
- 9984281751602771
Metrics
10 Record Views